Login
logo dark logo light logo
  • About EUnetHTA
    • EUnetHTA
      • JA 3 (2016-2020)
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
    • EUnetHTA Network
    • Organisation
      • The Executive Board
      • The Secretariat
    • Vision, Mission, and Values
    • EUnetHTA and the HTA Network
    • EUnetHTA Magazine
      • Winter 2020
      • Autumn 2019
      • Summer 2019
      • Winter 2018-2019
      • Autumn 2018
      • Summer 2018
      • Spring 2018
      • Winter 2017 – 2018
      • Autumn 2017
    • Acronyms
  • Covid-19 Response
    • Diagnostics
    • Treatments
    • Useful Links
  • Services
    • Assessment Submission
    • Early Dialogues
      • Early Dialogues for Pharmaceutical Products
      • Early Dialogues for Medical Devices
    • PLEG
  • Assessments
    • EUnetHTA Prioritisation List (EPL) – Pharmaceuticals
    • EUnetHTA Prioritisation List (EPL) – Other Technologies
    • Assessments REA (2016 – 2021)
    • Topic Identification, Selection and Prioritisation
    • National Uptake and Case Studies
    • PICO FAQ
    • Assessment Archive (2006 – 2015)
    • Assessment FAQ
  • Tools
    • HTA Core Model®
    • Methodology
    • REQueST® Tool
    • POP Database
    • EVIDENT Database
    • Declaration of Interest (DOI)
    • Submission Template for Pharma and Med. Devices
    • Companion Guide
    • Tools Archive
      • HTA Adaptation Toolkit
  • Get Involved
    • Patients
    • Industry
    • Health Care Professionals
    • Payers
    • Events
      • 2021 EUnetHTA Forum
      • 2020 EUnetHTA Forum
      • 2019 EUnetHTA Forum
      • 2018 EUnetHTA Forum
      • 2017 EUnetHTA Forum
      • Upcoming Events
Mobile Logo
  • About EUnetHTA
    • EUnetHTA
      • JA 3 (2016-2020)
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
    • EUnetHTA Network
    • Organisation
      • The Executive Board
      • The Secretariat
    • Vision, Mission, and Values
    • EUnetHTA and the HTA Network
    • EUnetHTA Magazine
      • Winter 2020
      • Autumn 2019
      • Summer 2019
      • Winter 2018-2019
      • Autumn 2018
      • Summer 2018
      • Spring 2018
      • Winter 2017 – 2018
      • Autumn 2017
    • Acronyms
  • Covid-19 Response
    • Diagnostics
    • Treatments
    • Useful Links
  • Services
    • Assessment Submission
    • Early Dialogues
      • Early Dialogues for Pharmaceutical Products
      • Early Dialogues for Medical Devices
    • PLEG
  • Assessments
    • EUnetHTA Prioritisation List (EPL) – Pharmaceuticals
    • EUnetHTA Prioritisation List (EPL) – Other Technologies
    • Assessments REA (2016 – 2021)
    • Topic Identification, Selection and Prioritisation
    • National Uptake and Case Studies
    • PICO FAQ
    • Assessment Archive (2006 – 2015)
    • Assessment FAQ
  • Tools
    • HTA Core Model®
    • Methodology
    • REQueST® Tool
    • POP Database
    • EVIDENT Database
    • Declaration of Interest (DOI)
    • Submission Template for Pharma and Med. Devices
    • Companion Guide
    • Tools Archive
      • HTA Adaptation Toolkit
  • Get Involved
    • Patients
    • Industry
    • Health Care Professionals
    • Payers
    • Events
      • 2021 EUnetHTA Forum
      • 2020 EUnetHTA Forum
      • 2019 EUnetHTA Forum
      • 2018 EUnetHTA Forum
      • 2017 EUnetHTA Forum
      • Upcoming Events

Blog

Home  /  Outputs   /  EUnetHTA Joint Action 2 (2012-15)   /  HTA Core Model_ Guiding principles on use
January 20, 2015
EUnetHTA Joint Action 2 (2012-15), JA2-WP8, Outputs

HTA Core Model_ Guiding principles on use

The HTA Core Model_Guiding principles on use_20151218

By admin
0
0

OUR NETWORK

  • EUnetHTA Network
  • JA 3 (2016-2020)
  • JA 2 Archive (2012-2015)
  • JA 1 Archive (2010-2012)
  • EUnetHTA Collaboration (2009)
  • EUnetHTA Project (2006-2008)

CAREERS

  • Work with EUnetHTA

HELP

Email: eunethta@zinl.nl

CONTACT US

  • Media and Press
  • Disclaimer
  • Reusing our content
  • Terms of use
  • Privacy Policy

This website is part of joint action ‘724130 / EUnetHTA JA3’ which has received funding from the European Union’s Health Programme (2014-2020).

©2018 EUnetHTA All rights reserved.